Franklin Dedominicis, PA
Physician Assistant · Hamden, CTNPI 1871031492
Payments from drug & device makers
Across 546 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$2K
- GSK$1K
- Otsuka America Pharmaceutical, Inc.$853
- Novo Nordisk$801
- Lilly USA, LLC$424
- plus $3K from 25 others
What the payments were for
- Food & beverage$9,838100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 162 | $2,288 |
| AstraZeneca | 83 | $1,693 |
| GSK | 68 | $1,230 |
| Otsuka America Pharmaceutical, Inc. | 40 | $853 |
| Novo Nordisk | 45 | $801 |
| Lilly USA, LLC | 22 | $424 |
| Merck | 17 | $345 |
| Pfizer | 18 | $304 |
| Exact Sciences | 13 | $284 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $282 |
| Axsome Therapeutics, Inc. | 7 | $183 |
| Amgen | 8 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $156 |
| Lundbeck LLC | 6 | $134 |
| Boehringer Ingelheim | 5 | $105 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $91 |
| Almatica Pharma LLC | 4 | $79 |
| Inspire Medical Systems, Inc. | 3 | $74 |
| Amarin Pharma, Inc. | 4 | $70 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Eisai Inc. | 2 | $29 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Bayer | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$9,838 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 55 | $97,348 |
| OzempicSemaglutide | 60 | $77,461 |
| JanuviaSitagliptin Phosphate | 27 | $33,168 |
| EliquisApixaban | 20 | $21,511 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $20,974 |
| VraylarCariprazine Hcl | 14 | $19,554 |
| TradjentaLinagliptin | 20 | $18,929 |
| JardianceEmpagliflozin | 13 | $18,032 |
| FarxigaDapagliflozin Propanediol | 17 | $17,842 |
| TrintellixVortioxetine Hydrobromide | 20 | $17,563 |
| Varenicline Tartrate | 12 | $2,545 |
| Ventolin HfaAlbuterol Sulfate | 22 | $2,520 |
| Dexlansoprazole DrDexlansoprazole | 13 | $2,333 |
| Atorvastatin Calcium | 187 | $2,025 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,955 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $424 | $97,34855 claims |
| Novo NordiskOzempic | $801 | $77,46160 claims |
| Boehringer IngelheimTradjenta, Jardiance | $105 | $36,96133 claims |
| MerckJanuvia | $345 | $33,16827 claims |
| PfizerEliquis | $304 | $21,51120 claims |
| GSKTrelegy Ellipta | $1,230 | $20,97419 claims |
| AbbVieVraylar | $2,288 | $19,55414 claims |
| AstraZenecaFarxiga | $1,693 | $17,84217 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $156 | $17,56320 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $28 | $82034 claims |
| Almatica Pharma LLCSertraline Hcl | $79 | $59248 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Other physician assistant in Hamden
- Sara BalakrishnanHamden$13K
- Jessica NursickHamden$10K
- Jenna LangelloWaterbury$345K
- Gary SpinnerBridgeport$123K
- Jordan MarcouTrumbull$44K
- Mary ElliottGuilford$43K
- Christopher ThompsonGroton$42K
- Michael LalondeNew Haven$35K
- Kristine LaneMiddletown$30K
- Kathryn MidgleyNew Haven$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.